P Riederer

发表

[Biochemical aspects of human behavior].

L Ambrozi, W Birkmayer, W Danielczyk, 1973, Wiener Zeitschrift fur Nervenheilkunde und deren Grenzgebiete.

The neurotoxicity of iron and nitric oxide. Relevance to the etiology of Parkinson's disease.

P Riederer, P. Riederer, M. Youdim, 1993, Advances in neurology.

Advanced glycation end products in neurodegeneration: More than early markers of oxidative stress?

P Riederer, P. Riederer, M. Gerlach, 1998, Annals of neurology.

The AGNP-TDM Expert Group Consensus Guidelines: Therapeutic Drug Monitoring in Psychiatry

B Müller-Oerlinghausen, P Riederer, P. Riederer, 2004, Pharmacopsychiatry.

Quantitative analysis of the structural requirements for blockade of the N-methyl-D-aspartate receptor at the phencyclidine binding site.

P Riederer, J. Kornhuber, P. Riederer, 1998, Journal of medicinal chemistry.

Alterations in expression of glutamatergic transporters and receptors in sporadic Alzheimer's disease.

P Riederer, P. Riederer, R. Ravid, 2007, Journal of Alzheimer's disease : JAD.

Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients.

P Riederer, H. Przuntek, P. Riederer, 1995, Neuroscience letters.

Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes

M Gallorini, P Riederer, P. Riederer, 2001, Journal of neurochemistry.

Bimodal distribution of dopamine receptor densities in brains of schizophrenics.

P Riederer, K. Jellinger, G. Reynolds, 1984, Science.

Pathogenesis and preclinical course of Parkinson's disease.

P Riederer, P. Riederer, P. Foley, 1999, Journal of neural transmission. Supplementum.

A null mutation allele in the CNTF gene and schizophrenic psychoses.

P Riederer, H Beckmann, J Kornhuber, 1996, Neuroreport.

Combined enrichment of neuromelanin granules and synaptosomes from human substantia nigra pars compacta tissue for proteomic analysis.

P Riederer, L. Grinberg, R. Leite, 2013, Journal of proteomics.

Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017

K Domschke, P Riederer, Matthias J. Müller, 2017, Pharmacopsychiatry.

Iron in the Parkinsonian substantia nigra.

P Riederer, K. Jellinger, E. Hirsch, 1997, Movement disorders : official journal of the Movement Disorder Society.

Allelic Variation of Human Serotonin Transporter Gene Expression

P Riederer, K. Lesch, P. Riederer, 1996, Journal of neurochemistry.

Selective Increase of Iron in Substantia Nigra Zona Compacta of Parkinsonian Brains

P Riederer, K. Jellinger, P. Riederer, 1991, Journal of neurochemistry.

Free radical mechanisms in dementia of Alzheimer type and the potential for antioxidative treatment.

P Riederer, L. Frölich, P. Riederer, 1995, Arzneimittel-Forschung.

Iron accumulation in the substantia nigra in rats visualized by ultrasound.

G Becker, C Grote, W Wesemann, 1999, Ultrasound in medicine & biology.

Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases.

P Riederer, K. Jellinger, G. Reynolds, 1987, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

pH measurement as quality control on human post mortem brain tissue: a study of the BrainNet Europe consortium

G Halliday, P Riederer, P Falkai, 2009, Neuropathology and applied neurobiology.